The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans

Clinical Genetics

Volumn 63, Issue 1, 2003, Pages 31-38

  Park, K W ^a,b   Choi, J H ^a   Kim, H K ^a,b   Oh, S ^a,b   Chae, I H ^a,b   Kim, Hyo Soo ^a,b   Oh, B H ^a,b   Lee, M M ^a,b   Park, Y B ^a,b   Choi, Y S ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Cholesteryl ester transfer protein; Coronary artery disease; Genetic polymorphism; HDL C; Lipoprotein

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TAQ POLYMERASE; CARRIER PROTEIN; CETP PROTEIN, HUMAN; GLYCOPROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CHOLESTEROL METABOLISM; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; ETHNIC GROUP; FEMALE; GENDER; GENE CONTROL; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOTE; HUMAN; KOREA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; BLOOD; CORONARY ARTERY ATHEROSCLEROSIS; ETHNOLOGY; GENETIC POLYMORPHISM; GENETICS; HYPERLIPIDEMIA; MIDDLE AGED;

CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CORONARY ARTERIOSCLEROSIS; FEMALE; GLYCOPROTEINS; HUMANS; HYPERLIPIDEMIAS; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0037741056     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2003.630105.x     Document Type: Article

References (36)

1. Jarnagin AS, Kohr W, Fielding C. Isolation and specificity of a Mr 74,000 cholesteryl ester transfer protein from human plasma. Proc Natl Acad Sci USA 1987: 84: 1854-1857.
2. Bruce C, Chouinard RA Jr, Tall AR. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr 1998: 18: 297-330.
3. Tall AR. An overview of reverse cholesterol transport. Eur Heart J 1998: 19: A31-A35.
4. Tall AR. Plasma cholesterol ester transfer protein. J Lipid Res 1993: 34: 1255-1274.
5. Agellon LB, Walsh A, Hayek T et al. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem 1991: 266: 10796-10801.
6. Barter PJ, Rye KA. High density lipoproteins and coronary heart disease. Atherosclerosis 1996: 121: 1-12.
7. Fumeron F, Betoulle D, Luc G et al. Alcohol intake modulates the effect of a polymorphism of the cholesterol ester transferprotein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995: 96: 1664-1671.
8. Bernard S, Moulin P, Lagrost L et al. Association between plasma HDL-cholesterol concentration and Taq1B CETP gene polymorphism in non-insulin-dependent diabetes mellitus. J Lipid Res 1998: 39: 59-65.
9. Gudnason V, Kakko S, Nicaud V et al. Cholesteryl ester transfer protein gene effects on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur J Clin Invest 1999: 29: 116-128.
10. Kuivenhoven JA, de Knijff P, Boer JM et al. Heterogeneity at the CETP locus gene. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 1997: 17: 560-568.
11. Kuivenhoven JA, Jukema JW, Zwinderman AH et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med 1998: 338: 86-93.
12. Ordovas JM, Cupples LA, Corella D et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 2000: 20: 1323-1329.
13. Corbex M, Poirier O, Fumeron F et al. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet Epidemiol 2000: 19: 64-80.
14. Arca M, Montali A, Ombres D et al. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis. Clin Genet 2001: 60: 374-380.
15. Hong SH, Kim YR, Song J, Kim JQ. Genetic variations of cholesterol ester transfer protein gene in Koreans. Hum Biol 2001: 73: 815-821.
16. Kawasaki I, Tahara H, Emoto M, Shoji T, Nishizawa Y. Relationship between TaqIB cholesteryl ester transfer protein gene polymorphism and macrovascular complications in Japanese patients with type 2 diabetes. Diabetes 2002: 51: 871-874.
17. Goto A, Sasai K, Suzuki S et al. Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography. Atherosclerosis 2001: 159: 153-163.
18. Meguro S, Takei I, Murata M et al. Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes. Atherosclerosis 2001: 156: 151-156.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972: 18: 499-502.
20. Corella D, Saiz C, Guillen M et al. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population. Atherosclerosis 2000: 152: 367-376.
21. Chen J, Yokoyama T, Saito K, Yoshiike N, Date C, Tanaka H. Association of human cholesteryl ester transfer protein-TaqI polymorphisms with serum HDL cholesterol levels in a normolipemic Japanese rural population. J Epidemiol 2002: 12: 77-84.
22. Kark JD, Sinnreich R, Leitersdorf E, Friedlander Y, Shpitzen S, Luc G. Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol. Atherosclerosis 2000: 151: 509-518.
23. Hsu LA, Ko LY, Hsu KH, Ko YH, Lee YS. Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwanese Chinese. Hum Genet 2002: 110: 57-63.
24. Cuchel M, Wolfe ML, deLemos AS, Rader DJ. The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African-Americans than in Caucasians. Atherosclerosis 2002: 163: 169-174.
25. Freeman DJ, Packard CJ, Shepherd J, Gaffney D. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin Sci 1990: 79: 575-581.
26. Inazu A, Brown M, Hesler C et al. Increased high-density lipoprotein levels caused by a common cholesteryl ester transfer protein gene mutation. N Engl J Med 1990: 323: 1234-1238.
27. Kondo I, Berg K, Drayna D, Lawn R. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet 1989: 35: 49-56.
28. Kauma H, Savolainen MJ, Heikkila E et al. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum Genet 1996: 97: 156-162.
29. Tenkanen H, Koskinen P, Kontula K et al. Polymorphisms of the gene encoding cholesteryl ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet 1991: 87: 574-578.
30. Freeman DJ, Griffin BA, Holmes AP et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors: associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 1994: 14: 336-344.
31. Durlach A, Clavel C, Girard-Globa A, Durlach V. Sex-dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascular pathology in type II diabetic patients. J Clin Endocrinol Metab 1999: 84: 3656-3659.
32. Sprafka JM, Norsted SW, Folsom AR, Burke GL, Luepker RV. Life-style factors do not explain racial differences in high-density lipoprotein cholesterol: the Minnesota Heart Survey. Epidemiology 1992: 3: 156-163.
33. Mendis S, Shepherd J, Packard CJ, Gaffney D. Genetic variation in the cholesteryl ester transfer protein and apolipoprotein A-I genes and its relation to coronary heart disease in a Sri Lankan population. Atherosclerosis 1990: 83: 21-27.
34. Hayek T, Masucci-Magoulas L, Jiang X et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 1995: 96: 2071-2074.
35. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993: 364: 73-75.
36. Zhong S, Sharp DS, Grove JS et al. Increased coronary heart disease in Japanese-American men with mutations in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996: 97: 2917-2923.